Shared and Distinct Functions of Type I and Type III Interferons

被引:767
|
作者
Lazear, Helen M. [1 ]
Schoggins, John W. [2 ]
Diamond, Michael S. [3 ,4 ,5 ,6 ]
机构
[1] Univ N Carolina, Dept Microbiol & Immunol, Chapel Hill, NC 27599 USA
[2] Univ Texas Southwestern Med Ctr Dallas, Dept Microbiol, Dallas, TX 75390 USA
[3] Washington Univ, Sch Med, Dept Med, St Louis, MO 63110 USA
[4] Washington Univ, Sch Med, Dept Pathol & Immunol, St Louis, MO 63110 USA
[5] Washington Univ, Sch Med, Dept Mol Microbiol, St Louis, MO 63110 USA
[6] Washington Univ, Sch Med, Andrew M & Jane M Bursky Ctr Human Immunol & Immu, St Louis, MO 63110 USA
关键词
CHRONIC HEPATITIS-C; REGULATORY FACTOR FAMILY; T-CELL RESPONSES; IFN-LAMBDA; ZIKA VIRUS; ADJUVANT THERAPY; PEGINTERFERON ALPHA-2A; STIMULATED GENES; PEGYLATED INTERFERON-ALPHA-2B; ANTIVIRAL PROTECTION;
D O I
10.1016/j.immuni.2019.03.025
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Type I interferons (IFNs) (IFN-alpha,IFN-beta) and type III IFNs (IFN-lambda) share many properties, including induction by viral infection, activation of shared signaling pathways, and transcriptional programs. However, recent discoveries have revealed context-specific functional differences. Here, we provide a comprehensive review of type I and type III IFN activities, highlighting shared and distinct features from molecular mechanisms through physiological responses. Beyond discussing canonical antiviral functions, we consider the adaptive immune primin anti-tumor, and autoimmune functions of IFNs. We discuss a model wherein type III IFNs serve as a front-line defense that controls infection at epithelial barriers while minimizing damaging inflammatory responses, reserving the more potent type I IFN response for when local responses are insufficient. In this context, we discuss current therapeutic applications targeting these cytokine pathways and hignlignt gaps in understanding of the biology of type I and type III IFNs in health and disease.
引用
收藏
页码:907 / 923
页数:17
相关论文
共 50 条
  • [31] Unique and overlapping roles of type I and type III interferons in influenza pathology and therapy
    Wack, Andreas
    Davidson, Sophia
    Crotta, Stefania
    McCabe, Teresa
    Hessel, Edith
    Hartmann, Rune
    CYTOKINE, 2015, 76 (01) : 63 - 63
  • [32] The bacterial pathogen Listeria monocytogenes and the interferon family: type I, type II and type III interferons
    Dussurget, Olivier
    Bierne, Helene
    Cossart, Pascale
    FRONTIERS IN CELLULAR AND INFECTION MICROBIOLOGY, 2014, 4
  • [33] Antiviral activity of type I interferons and interleukins 29 and 28a (type III interferons) against Apeu virus
    de Freitas Almeida, Gabriel Magno
    de Oliveira, Danilo Bretas
    de Brito Magalhaes, Cintia Lopes
    Bonjardim, Claudio Antonio
    Peregrino Ferreira, Paulo Cesar
    Kroon, Erna Geessien
    ANTIVIRAL RESEARCH, 2008, 80 (03) : 302 - 308
  • [34] Protective Potentials of Type III Interferons in COVID-19 Patients: Lessons from Differential Properties of Type I- and III Interferons
    Jafarzadeh, Abdollah
    Nemati, Maryam
    Saha, Bhaskar
    Bansode, Yashwant D.
    Jafarzadeh, Sara
    VIRAL IMMUNOLOGY, 2021, 34 (05) : 307 - 320
  • [35] The evolution of the type I interferons
    Roberts, RM
    Liu, LM
    Guo, QT
    Leaman, D
    Bixby, J
    JOURNAL OF INTERFERON AND CYTOKINE RESEARCH, 1998, 18 (10): : 805 - 816
  • [36] Type I Interferons in NeuroHIV
    Thaney, Victoria E.
    Kaul, Marcus
    VIRAL IMMUNOLOGY, 2019, 32 (01) : 7 - 14
  • [37] Type I Interferons in Autoimmunity
    Fernandez-Ruiz, Ruth
    Niewold, Timothy B.
    JOURNAL OF INVESTIGATIVE DERMATOLOGY, 2022, 142 (3 PT B) : 793 - 803
  • [38] Signaling Pathways of Type I and Type III Interferons and Targeted Therapies in Systemic Lupus Erythematosus
    Chyuan, I-Tsu
    Tzeng, Hong-Tai
    Chen, Ji-Yih
    CELLS, 2019, 8 (09)
  • [39] Role of type I and type III interferons in intestinal immunity to homologous and heterologous rotavirus infection
    Lin, Jian-Da
    Feng, Ningguo
    Sen, Adrish
    Man, Murugabaskar
    Tseng, Hsiang-Chi
    McElrath, Constance
    Durbin, Russell K.
    Greenberg, Harry B.
    Durbin, Joan E.
    Kotenko, Sergei V.
    CYTOKINE, 2015, 76 (01) : 87 - 87
  • [40] Importance of Type I and III Interferons at Respiratory and Intestinal Barrier Surfaces
    Stanifer, Megan L.
    Guo, Cuncai
    Doldan, Patricio
    Boulant, Steeve
    FRONTIERS IN IMMUNOLOGY, 2020, 11